Skip to main content

Table 1 Comparison of demographic and clinical variables between survivors and non-survivors

From: Evaluation of objective and subjective indicators of death in a period of one year in a sample of prevalent patients under regular hemodialysis

Variables

Survivors

Non-survivors

Full sample

P

Sex

   Male

84 (60.0)

14 (66.6)

98 (60.9)

0.637

   Female

56 (40.0)

7 (33.4)

63 (39.1)

 

Age

43.1 ± 15.7

53.6 ± 11.9

44.5 ± 15.6

0.002

Socioeconomic status a

   B

4 (2.9)

3 (14.3)

7 (4.3)

 

   C

33 (23.6)

5 (23.8)

38 (23.6)

 

   D

81 (57.9)

13 (61.9)

94 (58.4)

 

   E

22 (15.7)

0

22 (13.7)

 

Primary kidney disease

   Glomerulonephritis

64 (45.7)

5 (23.8)

69 (42.9)

0.063

   Hypertension

31 (22.1)

7 (33.4)

38 (23.6)

0.276

   Diabetes

12 (8.6)

4 (19.0)

16 (9.9)

0.230

   Policystic kidney

9 (6.4)

2 (9.5)

11 (6.8)

0.117

   Obstructive uropathy

6 (4.2)

1 (4.8)

7 (4.3)

1.000

   Lupus

4 (2.9)

0

4 (2.5)

1.000

   Chronic pyelonephritis

4 (2.9)

0

4 (2.5)

0.658

   Indeterminate

10 (7.2)

2 (9.5)

12 (7.5)

1.000

Time on dialysis (months)

55.4 ± 52.8

50.9 ± 39.5

54.8 ± 51.2

0.989

Comorbidity b

   Low

115 (82.2)

11 (52.4)

126 (78.3)

0.002

   Medium

22 (15.7)

6 (28.6)

28 (17.4)

 

   High

3 (2.1)

4 (19.0)

7 (4.3)

 

Included on transplant waiting list

80 (57.1)

5 (23.8)

85 (52.7)

0.005

Laboratory tests

   Creatinine (mg/dl)

12.7 ± 3.6

11.8 ± 4.0

12.6 ± 3.6

0.140

   Hemoglobin (g/dl)

8.5 ± 1.7

8.2 ± 1.6

8.5 ± 1.7

0.665

   Albumin (g/dl)

4.3 ± 0.4

4.4 ± 0.5

4.3 ± 0.4

0.567

   Calcium-phosphorus product (mg2/dl2)

46.2 ± 13.0

49.6 ± 15.6

46.6 ± 13.4

0.476

   Kt/V index

1.5 ± 0.5

1.6 ± 0.5

1.5 ± 0.5

0.807

  1. Data are means ± SD, or percentages (in parentheses)
  2. aBrazilian Association of Research Institutes, B (best status) and E (worst status)
  3. bKhan index